Hi-Tech Pharmacal Co. (HITK) Beats Q4 Views on Top and Bottom
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts HITK Hot Sheet
Price: $43.49 --0%
Financial Fact:
BASIC INCOME PER SHARE: 0.6
Today's EPS Names:
HOVR, VFS, PGR, More
Financial Fact:
BASIC INCOME PER SHARE: 0.6
Today's EPS Names:
HOVR, VFS, PGR, More
Join SI Premium – FREE
Hi-Tech Pharmacal Co, Inc. (NASDAQ: HITK) reported Q4 EPS of $1.08, $0.37 better than the analyst estimate of $0.71. Revenue for the quarter came in at $57.2 million versus the consensus estimate of $49.33 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Misses Q3 EPS by 20c, Beats on Revenue; Cuts FY EPS Guidance
- Samsung 3q Oper Profit 107.40t Won, Est. 108.67t Won - Bloomberg
- Lg Energy 3q Oper Profit 756.0b Won, Est. 365.48b Won - Bloomberg
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
